{"id":354955,"date":"2019-04-12T18:10:02","date_gmt":"2019-04-12T18:10:02","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=354955"},"modified":"2019-04-12T18:10:02","modified_gmt":"2019-04-12T18:10:02","slug":"hospital-acquired-infections-market-2019-global-industry-analysis-report-future-plans-business-distribution-application-deployment-type-to-witness-comprehensive-growth-business-opportunities","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/hospital-acquired-infections-market-2019-global-industry-analysis-report-future-plans-business-distribution-application-deployment-type-to-witness-comprehensive-growth-business-opportunities_354955.html","title":{"rendered":"Hospital Acquired Infections Market 2019| Global Industry Analysis Report, Future Plans, Business Distribution, Application, Deployment Type, to Witness Comprehensive Growth, Business Opportunities"},"content":{"rendered":"
\n
“Hospital-acquired Infections Market Research Report- Global Forecast to 2022| MRFR”<\/div>\n<\/div>\n
Hospital Acquired Infections Market Information, by Pathogen Types (Viral, Bacterial and Fungal), by Method of Treatment (Sterilization, Chemical, Radiation), Infection Type (Urinary Tract Infections, Blood Stream Infections, Surgical Site Infections, Gastrointestinal Infections, and Respiratory Infections) – Forecast till 2022<\/div>\n

The global hospital acquired infection market is expected to catapult to USD 36.16 billion by the end of 2022 from USD 23.7 billion in 2016, reveals Market Research Future (MRFR) in a minutely analyzed research report. Despite being equipped with state-of-the-art disinfecting technologies, hospital acquired infections continue to prevail in hospitalized patients and are the primary driver of the market which will help it to capture a CAGR of 7.3% over the forecast period of 2013-2022. Bacterial load in hospitals, crowding, temperature, and humidity raise the incidence of HAIs which necessitates diagnosis and treatment. Surging healthcare expenditures urges healthcare service providers to reuse medical equipment and supplies which increases the risk of infections in an inadvertent manner.<\/p>\n

The rise in global geriatric population also contributes to the growth of the hospital acquired infection market. The aged population is vulnerable to acquiring infections from hospitals since they have decreased immunity. The market is expected to experience induced demand for treatment and diagnosis from the developing regions. Poor healthcare infrastructure and lack of proper hygiene in healthcare institutions in developing and underdeveloped economies is a major cause of increase HAIs. However, installation of sterilization equipment and decline of hospital acquired infections in developed countries hamper the growth of the market. Technological advancements such as sterilization technology, increasing usage of disposables in healthcare, and increasing awareness regarding hospital acquired infections are likely to restrain the growth of the market. New guidelines and regulations aimed at curbing and preventing hospital acquired infections also limit the growth of the market.<\/p>\n

Download Free Sample Copy @ https:\/\/www.marketresearchfuture.com\/sample_request\/2576<\/a><\/strong><\/p>\n

Segmentation<\/strong><\/p>\n

The global hospital acquired infection market has been segmented based on pathogen types, method of treatment and infection type. By pathogen types, the market has been segmented into viral, bacterial and fungal. By method of treatment, the market has been segmented into sterilization, chemical, and radiation. By infection type, the market has been segmented into urinary tract infections, bloodstream infections, surgical site infections, gastrointestinal infections, and respiratory infections.<\/p>\n

Global Hospital-acquired Infections Market – Regional analysis<\/strong><\/p>\n

The North America region heading with the well-established healthcare sector accounts for the dominating market for hospital-acquired infections<\/strong><\/a>, globally. Furthermore, factors such as the higher per capita health care expenditures and growing investments into R&D to develop new techniques to cure hospital-acquired infections act as major growth drivers.<\/p>\n

The U.S. and Canada led by the large hospital admissions, patient population, and increasing prevalence hospital-acquired infections, contribute to the growth of the regional market majorly. Moreover, broadening insurance coverage alongside the expanding private healthcare sector and improving overall healthcare infrastructure are fostering the growth of the regional market.  The hospital-acquired infections market in North America is expected to reach around USD 12 BN by 2022.<\/p>\n

On the other hand, the hospital-acquired infections market in the European region accounts for the second-largest market, growing with strong healthcare penetration. Moreover, factors such as the availability of advanced treatment facilities, skilled medical professionals, and government support for research & development drive the growth of the regional market.<\/p>\n

The Asia Pacific hospital-acquired infections market is rapidly emerging as a lucrative market, globally. Countries such as India and China backed by the vast population and the low-cost medications and procedures available to treat the hospital-acquired infections foster the growth in the regional market. Furthermore, the rapidly growing healthcare sector coupled with the large unmet needs will provide impetus to the market growth over the forecast period.<\/p>\n

Global Hospital-acquired Infections Market – Competitive Analysis<\/strong><\/p>\n

Highly competitive, the hospital-acquired infections market appears to be fragmented characterized by the presence of several large and small players. Well-established players incorporate strategic initiatives such as acquisition, collaboration, partnership, technology launch, and expansion to gain a competitive advantage in this market and to maintain their market position. Focusing on therapeutic areas with a high unmet medical need, these companies assess areas that require further innovation over the progress that has been made.<\/p>\n

High growth potential that the market demonstrates attracts several new entrants to the market which further results in intensifying the competition. Substantial investments are transpired in R&D and clinical trials by the top players to develop effective treatments for these infections. These players are holding significant market share while other small and medium-sized companies are growing as well.<\/p>\n

Major Players:<\/strong><\/p>\n

Key players leading the global hospital-acquired infections market include 3M Company, Advanced Sterilization Products, Becton Dickinson and company, Getinge AB, STERIS Corporation, Cantel Medical Corp., and Belimed AG among others.<\/p>\n

Industry\/Innovations\/Related News:<\/strong><\/p>\n

February 12, 2019 <\/strong>—- Royal Philips (the Netherlands), a global leader in health technology launched IntelliSpace Epidemiology, a solution that optimizes the detection of healthcare-associated infections (HAIs). Philips IntelliSpace Epidemiology is the only decision-support solution in the U.S. that combines clinical informatics and genomic sequencing information from pathogenic bacteria, aiming to assist infection control prevention teams in identifying infection transmissions efficiently.<\/p>\n

February 12, 2019 —- <\/strong>Medline Industries, Inc. (the US), a leading global manufacturer and distributor of medical supplies providing products, education, and services launched its new FDA-approved ReadyPrep CHG cloths to battle post-operative hospital-acquired infections. ReadyPrep CHG cloths are pre-saturated with 2% chlorhexidine gluconate, an antiseptic known for its ability to remove infection-causing bacteria from the skin.<\/p>\n

Read Complete Report @ https:\/\/www.marketresearchfuture.com\/reports\/hospital-acquired-infections-market-2576<\/a><\/strong><\/p>\n

About Market Research Future:<\/strong><\/p>\n

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.<\/p>\n

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.<\/p>\n

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.<\/p>\n

 <\/strong><\/p>\n

 <\/p>\n

 <\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Market Research Future<\/a>
Contact Person:<\/strong> Abhishek Sawant
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9312
Address:<\/strong>Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> https:\/\/www.marketresearchfuture.com\/reports\/polyalkylene-glycol-market-5081<\/a><\/p>\n

 <\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Hospital-acquired Infections Market Research Report- Global Forecast to 2022| MRFR” Hospital Acquired Infections Market Information, by Pathogen Types (Viral, Bacterial and Fungal), by Method of Treatment (Sterilization, Chemical, Radiation), Infection Type (Urinary Tract Infections, Blood Stream Infections, Surgical Site Infections, … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-354955","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/354955","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=354955"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/354955\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=354955"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=354955"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=354955"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}